These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 21983857)

  • 1. A crucial requirement for Hedgehog signaling in small cell lung cancer.
    Park KS; Martelotto LG; Peifer M; Sos ML; Karnezis AN; Mahjoub MR; Bernard K; Conklin JF; Szczepny A; Yuan J; Guo R; Ospina B; Falzon J; Bennett S; Brown TJ; Markovic A; Devereux WL; Ocasio CA; Chen JK; Stearns T; Thomas RK; Dorsch M; Buonamici S; Watkins DN; Peacock CD; Sage J
    Nat Med; 2011 Oct; 17(11):1504-8. PubMed ID: 21983857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer.
    Szczepny A; Rogers S; Jayasekara WSN; Park K; McCloy RA; Cochrane CR; Ganju V; Cooper WA; Sage J; Peacock CD; Cain JE; Burgess A; Watkins DN
    Oncogene; 2017 Sep; 36(39):5544-5550. PubMed ID: 28581526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.
    Cochrane CR; Vaghjiani V; Szczepny A; Jayasekara WSN; Gonzalez-Rajal A; Kikuchi K; McCaughan GW; Burgess A; Gough DJ; Watkins DN; Cain JE
    J Clin Invest; 2020 Aug; 130(8):4006-4018. PubMed ID: 32568216
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jia D; Augert A; Kim DW; Eastwood E; Wu N; Ibrahim AH; Kim KB; Dunn CT; Pillai SPS; Gazdar AF; Bolouri H; Park KS; MacPherson D
    Cancer Discov; 2018 Nov; 8(11):1422-1437. PubMed ID: 30181244
    [No Abstract]   [Full Text] [Related]  

  • 5. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer.
    Watkins DN; Berman DM; Burkholder SG; Wang B; Beachy PA; Baylin SB
    Nature; 2003 Mar; 422(6929):313-7. PubMed ID: 12629553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
    Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J
    Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
    Ferone G; Song JY; Krijgsman O; van der Vliet J; Cozijnsen M; Semenova EA; Adams DJ; Peeper D; Berns A
    Cell Rep; 2020 Mar; 30(11):3837-3850.e3. PubMed ID: 32187553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Inhibition of the E3 Ligase SCF
    Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
    Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
    Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
    Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain and hedgehog pathway targets in small cell lung cancer.
    Kaur G; Reinhart RA; Monks A; Evans D; Morris J; Polley E; Teicher BA
    Cancer Lett; 2016 Feb; 371(2):225-39. PubMed ID: 26683772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genomic profiles of small cell lung cancer.
    George J; Lim JS; Jang SJ; Cun Y; Ozretić L; Kong G; Leenders F; Lu X; Fernández-Cuesta L; Bosco G; Müller C; Dahmen I; Jahchan NS; Park KS; Yang D; Karnezis AN; Vaka D; Torres A; Wang MS; Korbel JO; Menon R; Chun SM; Kim D; Wilkerson M; Hayes N; Engelmann D; Pützer B; Bos M; Michels S; Vlasic I; Seidel D; Pinther B; Schaub P; Becker C; Altmüller J; Yokota J; Kohno T; Iwakawa R; Tsuta K; Noguchi M; Muley T; Hoffmann H; Schnabel PA; Petersen I; Chen Y; Soltermann A; Tischler V; Choi CM; Kim YH; Massion PP; Zou Y; Jovanovic D; Kontic M; Wright GM; Russell PA; Solomon B; Koch I; Lindner M; Muscarella LA; la Torre A; Field JK; Jakopovic M; Knezevic J; Castaños-Vélez E; Roz L; Pastorino U; Brustugun OT; Lund-Iversen M; Thunnissen E; Köhler J; Schuler M; Botling J; Sandelin M; Sanchez-Cespedes M; Salvesen HB; Achter V; Lang U; Bogus M; Schneider PM; Zander T; Ansén S; Hallek M; Wolf J; Vingron M; Yatabe Y; Travis WD; Nürnberg P; Reinhardt C; Perner S; Heukamp L; Büttner R; Haas SA; Brambilla E; Peifer M; Sage J; Thomas RK
    Nature; 2015 Aug; 524(7563):47-53. PubMed ID: 26168399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
    Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells Lacking the
    Oser MG; Fonseca R; Chakraborty AA; Brough R; Spektor A; Jennings RB; Flaifel A; Novak JS; Gulati A; Buss E; Younger ST; McBrayer SK; Cowley GS; Bonal DM; Nguyen QD; Brulle-Soumare L; Taylor P; Cairo S; Ryan CJ; Pease EJ; Maratea K; Travers J; Root DE; Signoretti S; Pellman D; Ashton S; Lord CJ; Barry ST; Kaelin WG
    Cancer Discov; 2019 Feb; 9(2):230-247. PubMed ID: 30373918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung Cancer.
    Lim S; Lim SM; Kim MJ; Park SY; Kim JH
    Yonsei Med J; 2019 Oct; 60(10):898-904. PubMed ID: 31538424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
    Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
    Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
    Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mesenchymal-like subpopulation in non-neuroendocrine SCLC contributes to metastasis.
    Jin Y; Xiao T; Feng Y; Yang J; Guo C; Hu L; Ji H
    J Genet Genomics; 2021 Jul; 48(7):571-581. PubMed ID: 34373217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response.
    Akeno N; Reece AL; Callahan M; Miller AL; Kim RG; He D; Lane A; Moulton JS; Wikenheiser-Brokamp KA
    Mol Cancer Ther; 2017 Dec; 16(12):2913-2926. PubMed ID: 28847987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.